Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Nucleotide Compound Library

Catalog No. L1720

Nucleoside analogues are nucleosides which contain a nucleic acid analogue and a sugar. Nucleotide analogs are nucleotides which contain a nucleic acid analogue, a sugar, and one to three phosphate groups. Nucleoside and nucleotide analogues can be used in therapeutic drugs, include a range of antiviral products used to prevent viral replication in infected cells. These agents can be used against hepatitis B virus, hepatitis C virus, herpes simplex, and HIV. Among the current anti-viral drugs, almost 50% are nucleoside or nucleotide analogues. Anti-tumor drugs such as Cytarabine and Doxifluridine are also nucleotide analogues. The recently developed nucleoside analogues include HIV reverse transcriptase inhibitors Zidovudine, Didanosine, Zalcitabine, Stavudine, Lamivudine; Vidarabine, an antiviral drug which is active against herpes simplex and varicella zoster viruses; Acyclovir and Famciclovir, used for the treatment of herpes simplex virus infections; Ribavirin, also known as tribavirin, is an antiviral medication used to treat RSV infection, hepatitis C and some viral hemorrhagic fevers. TargetMol ‘s nucleotide compound library collects 334 nucleoside and nucleotide analogues, some of which are in the clinical trial phases or marketed therapeutic drugs, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
PDF
Contact us for more batch information

Catalog No. L1720

Nucleotide Compound Library
sizeIn stock
  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Product Description Product Description

  • A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
  • Some compounds are in the clinical trial phases or market therapeutic drugs;
  • Detailed compound information with structure, target, and biological activity description;
  • NMR and HPLC validated to ensure high purity and quality.

Packaging And Storage | TargetMol Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Library Customization | TargetMol Library Composition

Endogenous Metabolite
Nucleoside Antimetabolite/Analog
DNA/RNA Synthesis
Apoptosis
HIV Protease
Reverse Transcriptase
Adenosine Receptor
Autophagy
HCV Protease
HSV
Antibiotic
HBV
Antibacterial
Antiviral
SARS-CoV
Influenza Virus
DNA Methyltransferase
AChR
P2Y Receptor
AMPK
Histone Methyltransferase
PKA
PDE
Drug Metabolite
Antifection
Dehydrogenase
Antifungal
P2X Receptor
ROS
GPR
Thyroid hormone receptor(THR)
Dopamine Receptor
Mitophagy
Rho
Adrenergic Receptor
CDK
Telomerase
TLR
STAT
HDAC
NF-κB
Adenosine deaminase
TNF
Proteasome
Adenylyl cyclase
p38 MAPK
YAP
PI3K
NADPH
Histamine Receptor
JNK
Virus Protease
c-Myc
Tyrosine Kinases
Parasite
Serine/threonin kinase
PKC
ERK
Immunology/Inflammation related
Topoisomerase
IRE1
PROTAC Linker
IL Receptor
CXCR
MMP
Xanthine Oxidase
Norepinephrine
DUB
Interleukin
Akt
P-gp
HSP
Aminopeptidase
Sirtuin
CD73
RSV
ribosome
CRISPR/Cas9
5-HT Receptor
FLT
Ras
Tyrosinase
NOD-like Receptor (NLR)
NO Synthase

Keywords